The Therapeutic Nuclear Medicines Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Therapeutic Nuclear Medicines Market. With the use of historic data from (period), the Therapeutic Nuclear Medicines Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.

The global Therapeutic Nuclear Medicines Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in this market include

• Bayer
• Novartis AG
• China Isotope & Radiation
• Dongcheng
• Q BioMed
• Curium Pharmaceuticals
• Jubilant DraxImage
• Lantheus
• Spectrum Pharmaceuticals
• Progenics Pharmaceuticals
• International Isotopes

On the basis of region, the market is divided into:

• North America (U.S., and Canada)


• Latin America (Brazil, Mexico, Argentina, Columbia, and Rest of Latin America)


• Europe (Germany, the U.K., France, Russia, Italy, and Rest of Europe)


• Asia Pacific (China, Japan, South Korea, India, Southeast Asia, and Rest of Asia Pacific)


• Middle East (Saudi Arabia, UAE, Egypt, and Rest of Middle East)


• Africa (North Africa, Central Africa, and South Africa)

By the product type, the market is primarily segmented into

• Radium-223
• Lutetium-177
• Iodine-131
• Other

By the End-user Applications, the market is primarily segmented into

• Thyroid
• Bone Metastasis
• Lymphoma
• Other

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
  
  
  
  • United States
  
  
  • Canada
  
  
  • Mexico
  
  
  
  


• Asia Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • South Korea
  
  
  • India
  
  
  • Australia
  
  
  • Indonesia
  
  
  • Thailand
  
  
  • Malaysia
  
  
  • Philippines
  
  
  • Vietnam
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Russia
  
  
  
  


• Central & South America
  
  
  
  • Brazil
  
  
  
  


• Middle East & Africa
  
  
  
  • Turkey
  
  
  • GCC Countries
  
  
  • Egypt
  
  
  • South Africa
  
  
  
  

Key Highlights of the Report:

• Growth opportunities in the global Therapeutic Nuclear Medicines Market across major regions during the forecast period.


• Role of emerging markets in the global Therapeutic Nuclear Medicines Market and the scenario during the 2020-2026.


• Technological and product developments that influence growth of the market.


• New trends and advancements in the global Therapeutic Nuclear Medicines Market.


• Insight on various product types and their respective market shares in the overall market.

The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

• Raw material suppliers


• Distributors/traders/wholesalers/suppliers


• Regulatory bodies, including government agencies and NGO


• Commercial research & development (R&D) institutions


• Importers and exporters


• Government organizations, research organizations, and consulting firms


• Trade associations and industry bodies


• End-use industries

Available Customizations

At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.

1 Study Coverage 1.1 Therapeutic Nuclear Medicines Product Introduction 1.2 Key Market Segments in This Study 1.3 Key Manufacturers Covered: Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue in 2019 1.4 Market by Type 1.4.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 1.4.2 Radium-223 1.4.3 Lutetium-177 1.4.4 Iodine-131 1.4.5 Other 1.5 Market by Application 1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 1.5.2 Thyroid 1.5.3 Bone Metastasis 1.5.4 Lymphoma 1.5.5 Other 1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Nuclear Medicines Industry Impact 1.6.1 How the Covid-19 is Affecting the Therapeutic Nuclear Medicines Industry 1.6.1.1 Therapeutic Nuclear Medicines Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Therapeutic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Therapeutic Nuclear Medicines Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts 2.1.1 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2015-2026 2.1.2 Global Therapeutic Nuclear Medicines Production Capacity Estimates and Forecasts 2015-2026 2.1.3 Global Therapeutic Nuclear Medicines Production Estimates and Forecasts 2015-2026 2.2 Global Therapeutic Nuclear Medicines Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Analysis of Competitive Landscape 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 2.3.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.3.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution 2.4 Key Trends for Therapeutic Nuclear Medicines Markets & Products 2.5 Primary Interviews with Key Therapeutic Nuclear Medicines Players (Opinion Leaders) 3 Market Size by Manufacturers 3.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Production Capacity 3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Production Capacity (2015-2020) 3.1.2 Global Top Therapeutic Nuclear Medicines Manufacturers by Production (2015-2020) 3.1.3 Global Top Therapeutic Nuclear Medicines Manufacturers Market Share by Production 3.2 Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue 3.2.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (2015-2020) 3.2.2 Global Top Therapeutic Nuclear Medicines Manufacturers Market Share by Revenue (2015-2020) 3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2019 3.3 Global Therapeutic Nuclear Medicines Price by Manufacturers 3.4 Mergers & Acquisitions, Expansion Plans 4 Therapeutic Nuclear Medicines Production by Regions 4.1 Global Therapeutic Nuclear Medicines Historic Market Facts & Figures by Regions 4.1.1 Global Top Therapeutic Nuclear Medicines Regions by Production (2015-2020) 4.1.2 Global Top Therapeutic Nuclear Medicines Regions by Revenue (2015-2020) 4.2 North America 4.2.1 North America Therapeutic Nuclear Medicines Production (2015-2020) 4.2.2 North America Therapeutic Nuclear Medicines Revenue (2015-2020) 4.2.3 Key Players in North America 4.2.4 North America Therapeutic Nuclear Medicines Import & Export (2015-2020) 4.3 Europe 4.3.1 Europe Therapeutic Nuclear Medicines Production (2015-2020) 4.3.2 Europe Therapeutic Nuclear Medicines Revenue (2015-2020) 4.3.3 Key Players in Europe 4.3.4 Europe Therapeutic Nuclear Medicines Import & Export (2015-2020) 4.4 China 4.4.1 China Therapeutic Nuclear Medicines Production (2015-2020) 4.4.2 China Therapeutic Nuclear Medicines Revenue (2015-2020) 4.4.3 Key Players in China 4.4.4 China Therapeutic Nuclear Medicines Import & Export (2015-2020) 4.5 Japan 4.5.1 Japan Therapeutic Nuclear Medicines Production (2015-2020) 4.5.2 Japan Therapeutic Nuclear Medicines Revenue (2015-2020) 4.5.3 Key Players in Japan 4.5.4 Japan Therapeutic Nuclear Medicines Import & Export (2015-2020) 5 Therapeutic Nuclear Medicines Consumption by Region 5.1 Global Top Therapeutic Nuclear Medicines Regions by Consumption 5.1.1 Global Top Therapeutic Nuclear Medicines Regions by Consumption (2015-2020) 5.1.2 Global Top Therapeutic Nuclear Medicines Regions Market Share by Consumption (2015-2020) 5.2 North America 5.2.1 North America Therapeutic Nuclear Medicines Consumption by Application 5.2.2 North America Therapeutic Nuclear Medicines Consumption by Countries 5.2.3 U.S. 5.2.4 Canada 5.3 Europe 5.3.1 Europe Therapeutic Nuclear Medicines Consumption by Application 5.3.2 Europe Therapeutic Nuclear Medicines Consumption by Countries 5.3.3 Germany 5.3.4 France 5.3.5 U.K. 5.3.6 Italy 5.3.7 Russia 5.4 Asia Pacific 5.4.1 Asia Pacific Therapeutic Nuclear Medicines Consumption by Application 5.4.2 Asia Pacific Therapeutic Nuclear Medicines Consumption by Regions 5.4.3 China 5.4.4 Japan 5.4.5 South Korea 5.4.6 India 5.4.7 Australia 5.4.8 Taiwan 5.4.9 Indonesia 5.4.10 Thailand 5.4.11 Malaysia 5.4.12 Philippines 5.4.13 Vietnam 5.5 Central & South America 5.5.1 Central & South America Therapeutic Nuclear Medicines Consumption by Application 5.5.2 Central & South America Therapeutic Nuclear Medicines Consumption by Country 5.5.3 Mexico 5.5.3 Brazil 5.5.3 Argentina 5.6 Middle East and Africa 5.6.1 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application 5.6.2 Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries 5.6.3 Turkey 5.6.4 Saudi Arabia 5.6.5 UAE 6 Market Size by Type (2015-2026) 6.1 Global Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 6.1.1 Global Therapeutic Nuclear Medicines Production by Type (2015-2020) 6.1.2 Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020) 6.1.3 Therapeutic Nuclear Medicines Price by Type (2015-2020) 6.2 Global Therapeutic Nuclear Medicines Market Forecast by Type (2021-2026) 6.2.1 Global Therapeutic Nuclear Medicines Production Forecast by Type (2021-2026) 6.2.2 Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026) 6.2.3 Global Therapeutic Nuclear Medicines Price Forecast by Type (2021-2026) 6.3 Global Therapeutic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 7 Market Size by Application (2015-2026) 7.2.1 Global Therapeutic Nuclear Medicines Consumption Historic Breakdown by Application (2015-2020) 7.2.2 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2021-2026) 8 Corporate Profiles 8.1 Bayer 8.1.1 Bayer Corporation Information 8.1.2 Bayer Overview and Its Total Revenue 8.1.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.1.4 Bayer Product Description 8.1.5 Bayer Recent Development 8.2 Novartis AG 8.2.1 Novartis AG Corporation Information 8.2.2 Novartis AG Overview and Its Total Revenue 8.2.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.2.4 Novartis AG Product Description 8.2.5 Novartis AG Recent Development 8.3 China Isotope & Radiation 8.3.1 China Isotope & Radiation Corporation Information 8.3.2 China Isotope & Radiation Overview and Its Total Revenue 8.3.3 China Isotope & Radiation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.3.4 China Isotope & Radiation Product Description 8.3.5 China Isotope & Radiation Recent Development 8.4 Dongcheng 8.4.1 Dongcheng Corporation Information 8.4.2 Dongcheng Overview and Its Total Revenue 8.4.3 Dongcheng Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.4.4 Dongcheng Product Description 8.4.5 Dongcheng Recent Development 8.5 Q BioMed 8.5.1 Q BioMed Corporation Information 8.5.2 Q BioMed Overview and Its Total Revenue 8.5.3 Q BioMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.5.4 Q BioMed Product Description 8.5.5 Q BioMed Recent Development 8.6 Curium Pharmaceuticals 8.6.1 Curium Pharmaceuticals Corporation Information 8.6.2 Curium Pharmaceuticals Overview and Its Total Revenue 8.6.3 Curium Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.6.4 Curium Pharmaceuticals Product Description 8.6.5 Curium Pharmaceuticals Recent Development 8.7 Jubilant DraxImage 8.7.1 Jubilant DraxImage Corporation Information 8.7.2 Jubilant DraxImage Overview and Its Total Revenue 8.7.3 Jubilant DraxImage Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.7.4 Jubilant DraxImage Product Description 8.7.5 Jubilant DraxImage Recent Development 8.8 Lantheus 8.8.1 Lantheus Corporation Information 8.8.2 Lantheus Overview and Its Total Revenue 8.8.3 Lantheus Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.8.4 Lantheus Product Description 8.8.5 Lantheus Recent Development 8.9 Spectrum Pharmaceuticals 8.9.1 Spectrum Pharmaceuticals Corporation Information 8.9.2 Spectrum Pharmaceuticals Overview and Its Total Revenue 8.9.3 Spectrum Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.9.4 Spectrum Pharmaceuticals Product Description 8.9.5 Spectrum Pharmaceuticals Recent Development 8.10 Progenics Pharmaceuticals 8.10.1 Progenics Pharmaceuticals Corporation Information 8.10.2 Progenics Pharmaceuticals Overview and Its Total Revenue 8.10.3 Progenics Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.10.4 Progenics Pharmaceuticals Product Description 8.10.5 Progenics Pharmaceuticals Recent Development 8.11 International Isotopes 8.11.1 International Isotopes Corporation Information 8.11.2 International Isotopes Overview and Its Total Revenue 8.11.3 International Isotopes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020) 8.11.4 International Isotopes Product Description 8.11.5 International Isotopes Recent Development 9 Production Forecasts by Regions 9.1 Global Top Therapeutic Nuclear Medicines Regions Forecast by Revenue (2021-2026) 9.2 Global Top Therapeutic Nuclear Medicines Regions Forecast by Production (2021-2026) 9.3 Key Therapeutic Nuclear Medicines Production Regions Forecast 9.3.1 North America 9.3.2 Europe 9.3.3 China 9.3.4 Japan 10 Therapeutic Nuclear Medicines Consumption Forecast by Region 10.1 Global Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 10.2 North America Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 10.3 Europe Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 10.4 Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 10.5 Latin America Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 10.6 Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Region (2021-2026) 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Therapeutic Nuclear Medicines Sales Channels 11.2.2 Therapeutic Nuclear Medicines Distributors 11.3 Therapeutic Nuclear Medicines Customers 12 Market Opportunities & Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Porter's Five Forces Analysis 13 Key Finding in The Global Therapeutic Nuclear Medicines Study 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer List of Table List of Tables Table 1. Therapeutic Nuclear Medicines Key Market Segments in This Study Table 2. Ranking of Global Top Therapeutic Nuclear Medicines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$) Table 4. Major Manufacturers of Radium-223 Table 5. Major Manufacturers of Lutetium-177 Table 6. Major Manufacturers of Iodine-131 Table 7. Major Manufacturers of Other Table 8. COVID-19 Impact Global Market: (Four Therapeutic Nuclear Medicines Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Therapeutic Nuclear Medicines Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Therapeutic Nuclear Medicines Players to Combat Covid-19 Impact Table 13. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application 2020-2026 (K Units) Table 14. Global Therapeutic Nuclear Medicines Market Size by Region in US$ Million: 2015 VS 2020 VS 2026 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019) Table 17. Therapeutic Nuclear Medicines Manufacturing Base Distribution and Headquarters Table 18. Manufacturers Therapeutic Nuclear Medicines Product Offered Table 19. Date of Manufacturers Enter into Therapeutic Nuclear Medicines Market Table 20. Key Trends for Therapeutic Nuclear Medicines Markets & Products Table 21. Main Points Interviewed from Key Therapeutic Nuclear Medicines Players Table 22. Global Therapeutic Nuclear Medicines Production Capacity by Manufacturers (2015-2020) (K Units) Table 23. Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2015-2020) Table 24. Therapeutic Nuclear Medicines Revenue by Manufacturers (2015-2020) (Million US$) Table 25. Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020) Table 26. Therapeutic Nuclear Medicines Price by Manufacturers 2015-2020 (USD/Unit) Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Therapeutic Nuclear Medicines Production by Regions (2015-2020) (K Units) Table 29. Global Therapeutic Nuclear Medicines Production Market Share by Regions (2015-2020) Table 30. Global Therapeutic Nuclear Medicines Revenue by Regions (2015-2020) (US$ Million) Table 31. Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2015-2020) Table 32. Key Therapeutic Nuclear Medicines Players in North America Table 33. Import & Export of Therapeutic Nuclear Medicines in North America (K Units) Table 34. Key Therapeutic Nuclear Medicines Players in Europe Table 35. Import & Export of Therapeutic Nuclear Medicines in Europe (K Units) Table 36. Key Therapeutic Nuclear Medicines Players in China Table 37. Import & Export of Therapeutic Nuclear Medicines in China (K Units) Table 38. Key Therapeutic Nuclear Medicines Players in Japan Table 39. Import & Export of Therapeutic Nuclear Medicines in Japan (K Units) Table 40. Global Therapeutic Nuclear Medicines Consumption by Regions (2015-2020) (K Units) Table 41. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions (2015-2020) Table 42. North America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 43. North America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) Table 44. Europe Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 45. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) Table 46. Asia Pacific Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 47. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020) (K Units) Table 48. Asia Pacific Therapeutic Nuclear Medicines Consumption by Regions (2015-2020) (K Units) Table 49. Latin America Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 50. Latin America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) Table 51. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 52. Middle East and Africa Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units) Table 53. Global Therapeutic Nuclear Medicines Production by Type (2015-2020) (K Units) Table 54. Global Therapeutic Nuclear Medicines Production Share by Type (2015-2020) Table 55. Global Therapeutic Nuclear Medicines Revenue by Type (2015-2020) (Million US$) Table 56. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020) Table 57. Therapeutic Nuclear Medicines Price by Type 2015-2020 (USD/Unit) Table 58. Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 59. Global Therapeutic Nuclear Medicines Consumption by Application (2015-2020) (K Units) Table 60. Global Therapeutic Nuclear Medicines Consumption Share by Application (2015-2020) Table 61. Bayer Corporation Information Table 62. Bayer Description and Major Businesses Table 63. Bayer Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 64. Bayer Product Table 65. Bayer Recent Development Table 66. Novartis AG Corporation Information Table 67. Novartis AG Description and Major Businesses Table 68. Novartis AG Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 69. Novartis AG Product Table 70. Novartis AG Recent Development Table 71. China Isotope & Radiation Corporation Information Table 72. China Isotope & Radiation Description and Major Businesses Table 73. China Isotope & Radiation Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 74. China Isotope & Radiation Product Table 75. China Isotope & Radiation Recent Development Table 76. Dongcheng Corporation Information Table 77. Dongcheng Description and Major Businesses Table 78. Dongcheng Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 79. Dongcheng Product Table 80. Dongcheng Recent Development Table 81. Q BioMed Corporation Information Table 82. Q BioMed Description and Major Businesses Table 83. Q BioMed Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 84. Q BioMed Product Table 85. Q BioMed Recent Development Table 86. Curium Pharmaceuticals Corporation Information Table 87. Curium Pharmaceuticals Description and Major Businesses Table 88. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 89. Curium Pharmaceuticals Product Table 90. Curium Pharmaceuticals Recent Development Table 91. Jubilant DraxImage Corporation Information Table 92. Jubilant DraxImage Description and Major Businesses Table 93. Jubilant DraxImage Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 94. Jubilant DraxImage Product Table 95. Jubilant DraxImage Recent Development Table 96. Lantheus Corporation Information Table 97. Lantheus Description and Major Businesses Table 98. Lantheus Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 99. Lantheus Product Table 100. Lantheus Recent Development Table 101. Spectrum Pharmaceuticals Corporation Information Table 102. Spectrum Pharmaceuticals Description and Major Businesses Table 103. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 104. Spectrum Pharmaceuticals Product Table 105. Spectrum Pharmaceuticals Recent Development Table 106. Progenics Pharmaceuticals Corporation Information Table 107. Progenics Pharmaceuticals Description and Major Businesses Table 108. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 109. Progenics Pharmaceuticals Product Table 110. Progenics Pharmaceuticals Recent Development Table 111. International Isotopes Corporation Information Table 112. International Isotopes Description and Major Businesses Table 113. International Isotopes Therapeutic Nuclear Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 114. International Isotopes Product Table 115. International Isotopes Recent Development Table 116. Global Therapeutic Nuclear Medicines Revenue Forecast by Region (2021-2026) (Million US$) Table 117. Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026) (K Units) Table 118. Global Therapeutic Nuclear Medicines Production Forecast by Type (2021-2026) (K Units) Table 119. Global Therapeutic Nuclear Medicines Revenue Forecast by Type (2021-2026) (Million US$) Table 120. North America Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units) Table 121. Europe Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units) Table 122. Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units) Table 123. Latin America Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units) Table 124. Middle East and Africa Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) (K Units) Table 125. Therapeutic Nuclear Medicines Distributors List Table 126. Therapeutic Nuclear Medicines Customers List Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 128. Key Challenges Table 129. Market Risks Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Fifures Figure 1. Therapeutic Nuclear Medicines Product Picture Figure 2. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2020 & 2026 Figure 3. Radium-223 Product Picture Figure 4. Lutetium-177 Product Picture Figure 5. Iodine-131 Product Picture Figure 6. Other Product Picture Figure 7. Global Therapeutic Nuclear Medicines Consumption Market Share by Application in 2020 & 2026 Figure 8. Thyroid Figure 9. Bone Metastasis Figure 10. Lymphoma Figure 11. Other Figure 12. Therapeutic Nuclear Medicines Report Years Considered Figure 13. Global Therapeutic Nuclear Medicines Revenue 2015-2026 (Million US$) Figure 14. Global Therapeutic Nuclear Medicines Production Capacity 2015-2026 (K Units) Figure 15. Global Therapeutic Nuclear Medicines Production 2015-2026 (K Units) Figure 16. Global Therapeutic Nuclear Medicines Market Share Scenario by Region in Percentage: 2020 Versus 2026 Figure 17. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Therapeutic Nuclear Medicines Production Share by Manufacturers in 2015 Figure 19. The Top 10 and Top 5 Players Market Share by Therapeutic Nuclear Medicines Revenue in 2019 Figure 20. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020) Figure 21. Therapeutic Nuclear Medicines Production Growth Rate in North America (2015-2020) (K Units) Figure 22. Therapeutic Nuclear Medicines Revenue Growth Rate in North America (2015-2020) (US$ Million) Figure 23. Therapeutic Nuclear Medicines Production Growth Rate in Europe (2015-2020) (K Units) Figure 24. Therapeutic Nuclear Medicines Revenue Growth Rate in Europe (2015-2020) (US$ Million) Figure 25. Therapeutic Nuclear Medicines Production Growth Rate in China (2015-2020) (K Units) Figure 26. Therapeutic Nuclear Medicines Revenue Growth Rate in China (2015-2020) (US$ Million) Figure 27. Therapeutic Nuclear Medicines Production Growth Rate in Japan (2015-2020) (K Units) Figure 28. Therapeutic Nuclear Medicines Revenue Growth Rate in Japan (2015-2020) (US$ Million) Figure 29. Global Therapeutic Nuclear Medicines Consumption Market Share by Regions 2015-2020 Figure 30. North America Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 31. North America Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 Figure 32. North America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019 Figure 33. U.S. Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 34. Canada Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 35. Europe Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 36. Europe Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 Figure 37. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019 Figure 38. Germany Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 39. France Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 40. U.K. Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 41. Italy Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 42. Russia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 43. Asia Pacific Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units) Figure 44. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 Figure 45. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Regions in 2019 Figure 46. China Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 47. Japan Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 48. South Korea Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 49. India Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 50. Australia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 53. Thailand Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 54. Malaysia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 55. Philippines Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 56. Vietnam Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 57. Latin America Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units) Figure 58. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 Figure 59. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019 Figure 60. Mexico Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 61. Brazil Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 62. Argentina Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 63. Middle East and Africa Therapeutic Nuclear Medicines Consumption and Growth Rate (K Units) Figure 64. Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019 Figure 65. Middle East and Africa Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019 Figure 66. Turkey Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 67. Saudi Arabia Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 68. UAE Therapeutic Nuclear Medicines Consumption and Growth Rate (2015-2020) (K Units) Figure 69. Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020) Figure 70. Global Therapeutic Nuclear Medicines Production Market Share by Type in 2019 Figure 71. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2015-2020) Figure 72. Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2019 Figure 73. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Type (2021-2026) Figure 74. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2021-2026) Figure 75. Global Therapeutic Nuclear Medicines Market Share by Price Range (2015-2020) Figure 76. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020) Figure 77. Global Therapeutic Nuclear Medicines Value (Consumption) Market Share by Application (2015-2020) Figure 78. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Application (2021-2026) Figure 79. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 80. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 81. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 82. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018 Figure 83. Q BioMed Total Revenue (US$ Million): 2019 Compared with 2018 Figure 84. Curium Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 85. Jubilant DraxImage Total Revenue (US$ Million): 2019 Compared with 2018 Figure 86. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Spectrum Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Progenics Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. International Isotopes Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Global Therapeutic Nuclear Medicines Revenue Forecast by Regions (2021-2026) (US$ Million) Figure 91. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Regions ((2021-2026)) Figure 92. Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026) (K Units) Figure 93. North America Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units) Figure 94. North America Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million) Figure 95. Europe Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units) Figure 96. Europe Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million) Figure 97. China Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units) Figure 98. China Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million) Figure 99. Japan Therapeutic Nuclear Medicines Production Forecast (2021-2026) (K Units) Figure 100. Japan Therapeutic Nuclear Medicines Revenue Forecast (2021-2026) (US$ Million) Figure 101. Global Therapeutic Nuclear Medicines Consumption Market Share Forecast by Region (2021-2026) Figure 102. Therapeutic Nuclear Medicines Value Chain Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. Bottom-up and Top-down Approaches for This Report Figure 107. Data Triangulation Figure 108. Key Executives Interviewed

Pediatric Diabetes Therapeutic Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Pediatric Diabetes Therapeutic Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...

Nuclear Medicine Cyclotron Systems Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Nuclear Medicine Cyclotron Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Global Medical Device Regulatory Affairs Market (2024 Edition): Analysis By Type (Diagnostic, Therapeutic), By Services, By Service Provider, By Region: Market Insights and Forecast (2020-2030) ...

Executive Summary Azoth Analytics has released a research report titled "Global Medical Device Regulatory Affairs Market (2024 Edition)" which provides a complete analysis of the Global Medical Device Regulatory Affairs industry in terms of market segmentation By Type (Diagnostic, Thera...

Therapeutic Critical Care Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Therapeutic Critical Care Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...

Hazardous Waste and Nuclear Cleaning Robots Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hazardous Waste and Nuclear Cleaning Robots Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...

Whole Body Cooling Therapeutic System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Whole Body Cooling Therapeutic System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Nuclear Reactor Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Nuclear Reactor Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...

Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...

Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...

Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...